financetom
Business
financetom
/
Business
/
SK Hynix says readying HBM4 production after completing internal certification
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SK Hynix says readying HBM4 production after completing internal certification
Sep 11, 2025 7:28 PM

SEOUL, Sept 12 (Reuters) - South Korea's SK Hynix ( HXSCF )

said on Friday it has completed its internal

certification process for next generation high-bandwidth memory

4(HBM4) chips and established a production system for customers.

In March, the South Korean chipmaker, a key supplier to AI

giant Nvidia ( NVDA ), said it had shipped its HBM4 12-layer

chip samples to customers, adding that the company aims to

complete preparations for mass production of 12-layer HBM4

products within the second half of this year.

HBM - a type of dynamic random access memory or DRAM

standard first produced in 2013 - involves stacking chips

vertically to save space and reduce power consumption, helping

to process the large volumes of data generated by complex AI

applications.

SK Hynix ( HXSCF ) shares hit a record high in morning trade, rising

as much as 7.3%, outpacing the benchmark KOSPI's 1.2% rise, as

analysts cited the company's HBM4 chip production plans.

Kim Sunwoo, a senior analyst at Meritz Security,

projected that SK Hynix's ( HXSCF ) HBM market share will remain in the

low 60% range in 2026, supported by early HBM4 supply to key

customers and the resulting first-mover advantage.

SK Hynix ( HXSCF ) is currently the main HBM supplier to Nvidia ( NVDA ),

although Samsung Electronics ( SSNLF ) and Micron

supply it with smaller volumes.

Samsung said in July that it had provided samples of its

HBM4 chips

to customers, with a plan to supply them next year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Carlisle Companies To Acquire Plasti-Fab, A Canadian Based Vertically Integrated Manufacturer Of Expanded Polystyrene Insulation Products
BRIEF-Carlisle Companies To Acquire Plasti-Fab, A Canadian Based Vertically Integrated Manufacturer Of Expanded Polystyrene Insulation Products
Oct 17, 2024
Oct 17 (Reuters) - Carlisle Companies Inc ( CSL ): * CARLISLE COMPANIES TO ACQUIRE PLASTI-FAB, A CANADIAN BASED VERTICALLY INTEGRATED MANUFACTURER OF EXPANDED POLYSTYRENE INSULATION PRODUCTS * CARLISLE COMPANIES INC ( CSL ) - TO PURCHASE PLASTI-FAB FOR $259.5 MILLION IN CASH * CARLISLE COMPANIES INC ( CSL ) - ACQUISITION TO ADD $0.30 ADJUSTED EPS IN 2025 Source...
BRIEF-Flex To Acquire Crown Technical Systems
BRIEF-Flex To Acquire Crown Technical Systems
Oct 17, 2024
Oct 17 (Reuters) - Flex Ltd ( FLEX ): * FLEX TO ACQUIRE CROWN TECHNICAL SYSTEMS * FLEX LTD ( FLEX ) - TRANSACTION EXPECTED TO BE ACCRETIVE IN FIRST YEAR * FLEX LTD ( FLEX ) - TO ACQUIRE CROWN TECHNICAL SYSTEMS FOR $325 MILLION Source text for Eikon: Further company coverage: ...
BRIEF-ehouse Acquires Pointer Creative To Enhance Shopify Creative, UX/UI, Design And Development Capabilities And Expand Its Presence In Apparel, Cosmetics And Beauty
BRIEF-ehouse Acquires Pointer Creative To Enhance Shopify Creative, UX/UI, Design And Development Capabilities And Expand Its Presence In Apparel, Cosmetics And Beauty
Oct 17, 2024
Oct 17 (Reuters) - Ehouse Global Inc ( EHOS ): * EHOUSE ACQUIRES POINTER CREATIVE TO ENHANCE SHOPIFY CREATIVE, UX/UI, DESIGN AND DEVELOPMENT CAPABILITIES AND EXPAND ITS PRESENCE IN APPAREL, COSMETICS AND BEAUTY Source text for Eikon: Further company coverage: ...
Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan
Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan
Oct 17, 2024
09:11 AM EDT, 10/17/2024 (MT Newswires) -- Kezar Life Sciences ( KZR ) said Thursday that its board of directors has unanimously rejected an unsolicited takeover bid from Concentra Biosciences saying it substantially undervalues the company. The company said Concentra Biosciences sought to acquire all of its outstanding common stock for $1.10 cash per share, as well as the possibility...
Copyright 2023-2026 - www.financetom.com All Rights Reserved